Fatty acid binding protein 4 in circulating leucocytes reflects atherosclerotic lesion progression in Apoe(-/-) mice. - Wikidata - wikimedia - TriplyDB

Fatty acid binding protein 4 in circulating leucocytes reflects atherosclerotic lesion progression in Apoe(-/-) mice.

Fatty acid binding protein 4 in circulating leucocytes reflects atherosclerotic lesion progression in Apoe(-/-) mice.

http://www.wikidata.org/entity/Q37294001

about

Adipocyte nuclei captured from VAT and SAT Gender difference in plasma fatty-acid-binding protein 4 levels in patients with chronic obstructive pulmonary disease Noncoding Transcribed Ultraconserved Region (T-UCR) uc.261 Participates in Intestinal Mucosa Barrier Damage in Crohn's Disease.

P2860

Q36086937-33BDD6FB-AAD4-42E3-BC1D-0295CFED2DC0 Q36628196-99D37ACE-CD8F-45E3-8F56-B342A31389B2 Q48933269-392153B2-39B2-4712-B87E-5E27DD727C85

P2860

Fatty acid binding protein 4 in circulating leucocytes reflects atherosclerotic lesion progression in Apoe(-/-) mice.

http://www.wikidata.org/entity/Q37294001

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 February 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Fatty acid binding protein 4 i ...... tic lesion progression in Apoe

@nl

Fatty acid binding protein 4 i ...... progression in Apoe(-/-) mice.

@en

type

label

Fatty acid binding protein 4 i ...... tic lesion progression in Apoe

@nl

Fatty acid binding protein 4 i ...... progression in Apoe(-/-) mice.

@en

prefLabel

Fatty acid binding protein 4 i ...... tic lesion progression in Apoe

@nl

Fatty acid binding protein 4 i ...... progression in Apoe(-/-) mice.

@en

P1433

Q37294001-2F59758C-04CA-4711-A470-1F7E04FEE338

P1476

Q37294001-2326AF1E-8E04-4649-9F9F-4942EA459040

P2093

Q37294001-6677278C-BE78-4A83-92F1-19BE22F8E8CD

Q37294001-6762868B-D4D5-4741-8E79-9EFAC30FF904

Q37294001-67645DE6-8D71-4D50-928C-4991CD9AF6F7

Q37294001-684E4E18-A1C7-45DE-9B48-4F58D9D8FD0B

Q37294001-79EBA0D3-FBDF-4779-BD47-7A060234DBB6

Q37294001-8AE18B24-11E5-4B4F-820B-F366003F3E3F

Q37294001-923A1848-9E25-4246-A8FD-D849A454E66C

P2860

Q37294001-00EAE35E-D14F-4E3C-8CE1-7448A52F42C8

Q37294001-054FA09C-2F5C-41CC-BF39-8A21ABEABBFB

Q37294001-0C0F0CDF-B286-466A-902F-E5FF3831E4F1

Q37294001-1AE3EB67-E380-451A-A811-91C525D0E27E

Q37294001-1D597B08-412C-456E-8B8C-6046FC4C0A7D

Q37294001-23A7C91A-90A8-4F48-A250-068DF9F56FB6

Q37294001-36671694-22FD-47E8-934F-B28A327118A4

Q37294001-487B5001-C778-41E0-81D4-4CF64D7D8A69

Q37294001-499CBEFA-AA01-45CA-A085-E7ADF8D6E442

Q37294001-53FA4CAC-1C68-4643-9202-56ECBD0B6766

P304

Q37294001-CC4A2071-2E04-4CE4-9834-84DFEA796716

P31

Q37294001-637A5E05-5411-44D3-AC9B-A3E10E071C37

P356

Q37294001-392D1D36-E726-4DE2-B2E1-E64EB6CB9749

P433

Q37294001-051690DF-32A2-4608-86EC-BE8B8F36FC9F

P478

Q37294001-4EE44A22-314D-475E-BBC8-4B3AA20F9CCA

P50

Q37294001-1FCC8980-71D6-4CA8-87EF-A010C3EDD0C5

P577

Q37294001-77DA0720-861B-4240-AAD2-E3F876ED2B69

P5875

Q37294001-AC37A43B-2630-4A22-9DC1-3F73DF545B80

P698

Q37294001-49C6700A-9C6B-4577-AB0C-E1F66C738DBB

P921

Q37294001-182CA4F5-A547-4FBA-8AA6-9F8C0B963C94

Q37294001-BB8E7BED-0E49-47FE-98DF-E9DD0394A4D4

P932

Q37294001-CF525B9F-C825-46D9-A500-E030E79137AE

P356

P1433

Journal of Cellular and Molecular Medicine

P1476

Fatty acid binding protein 4 i ...... progression in Apoe(-/-) mice

@en

P2093

Anders Gabrielsen

http://www.w3.org/2001/XMLSchema#string

Andreas Hermansson

http://www.w3.org/2001/XMLSchema#string

Gabrielle Paulsso n-Berne

http://www.w3.org/2001/XMLSchema#string

Gijs H van Puijvelde

http://www.w3.org/2001/XMLSchema#string

Göran K Hansson

http://www.w3.org/2001/XMLSchema#string

Hanna E Agardh

http://www.w3.org/2001/XMLSchema#string

Karl Gertow

http://www.w3.org/2001/XMLSchema#string

P2860

Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis

Transformation of arachidonic acid and homo-gamma-linolenic acid by rabbit polymorphonuclear leukocytes. Monohydroxy acids from novel lipoxygenases

Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2

The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities

Inflammation, atherosclerosis, and coronary artery disease

The pathogenesis of atherosclerosis: a perspective for the 1990s

Molecular prediction for atherogenic risks across different cell types of leukocytes.

Monocytes and neutrophils expressing myeloperoxidase occur in fibrous caps and thrombi in unstable coronary plaques.

Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice.

Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets.

P304

303-310

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JCMM.12011

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Dolores Salvado

P577

2013-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235414496

http://www.w3.org/2001/XMLSchema#string

P698

23387955

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

3822593

http://www.w3.org/2001/XMLSchema#string